Search enhanced by Google
Reginald Low, M.D.
Clinical Professor of Medicine
Reginald Low is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Lawrence J. Ellison Ambulatory Care Center
Cardiology Clinic
4860 Y St.
Sacramento, CA 95817
Fax: 800-348-0499
Additional Numbers
Physician Referrals
Clinical Interests
Dr. Low is a cardiologist specializing in the evaluation and management of complex cardiac patients and Interventional Cardiology. He provides personalized, compassionate, and evidenced based care for his patients. Dr. Low was the Chief of the Division of Cardiovascular Medicine from 2000 to 2019.
Division
Cardiovascular Medicine
Center/Program Affiliation
Undergraduate School
B.A., UCLA, Los Angeles CA 1969
Medical School
M.D., UC Davis School of Medicine, Sacramento CA 1975
Internship
UC Davis Medical Center, Sacramento CA 1975-1976
Residency
UC Davis Medical Center, Sacramento CA1976-1978
Fellowship
UC Davis Medical Center, Sacramento CA 1978-1980
Treede H, Tübler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, Mueller R, Low R, Bolling SF, Meinertz T, Schofer J. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J Thorac Cardiovasc Surg. 2010 Oct;140(4):897-903. doi:10.1016/j.jtcvs.2010.01.017. Epub 2010 Apr 14. PMID:20392455.
Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009 Aug 18;54(8):686-94. doi:10.1016/j.jacc.2009.03.077. PMID:19679246.
Li N, Liu JY, Timofeyev V, Qiu H, Hwang SH, Tuteja D, Lu L, Yang J, Mochida H, Low R, Hammock BD, Chiamvimonvat N. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol. 2009 Dec;47(6):835-45. doi:10.1016/j.yjmcc.2009.08.017. Epub 2009 Aug 28. PMID:19716829.
Rogers JH, Rahdert DA, Caputo GR, Takeda PA, Palacios IF, Tio FO, Taylor EA, Low RI. Long-term safety and durability of percutaneous septal sinus shortening (The PS(3) System) in an ovine model. Catheter Cardiovasc Interv. 2009 Mar 1;73(4):540-8. doi:10.1002/ccd.21818. PMID:19235241.
Taneja M, Tay KH, Sebastian M, Pasupathy S, Lin SE, Teo T, Low R, Irani FG, Chng SP, Dewan A, Tan BS. Self-expanding nitinol stents in recanalisation of long-length superficial femoral artery occlusions in patients with critical limb ischaemia. Singapore Med J. 2009 Dec;50(12):1184-8. PMID:20087556.
Low RI, Bolling SF, Yeo KK, Ebner A. Direct flow medical percutaneous aortic valve: proof of concept. EuroIntervention. 2008 Aug;4(2):256-61. PMID:19110792.
Fellmeth BD, Baron SB, Brown PR, Ang JG, Clayson KR, Morrison SL, Low R. Repair of postcatheterization femoral pseudoaneurysms by color flow ultrasound guided compression. AHJ. 1992 Feb;123(2)547-51. doi:10.1016/0002-8703(92)90682-l. PMID:1736601.
Lee G, Reis RL, Boggan MD, Chan MC, Lee MH, Low R, Hannah H 3d, Mason CT. Laser recanalization in severe end-stage peripheral vascular disease. Am J Cardiol. 1987 Feb 1;59(4):386-7. doi:10.1016/0002-9149(87)90830-7.
Low R, Takeda P, Lee G, Mason DT. Potential efficacy of calcium antagonists and heparin in patients with embolic strokes. Am Heart J. 1986 Dec;112(6):1338-9.
Lee G, Ikeda RM, Chan MC, Lee MH, Rink JL, Reis RL, Theis JH, Low R, Bommer WJ, Kung AH, et al. Limitations, risks and complications of laser recanalization: a cautious approach warranted. Am J Cardiol. 1985 Jul 1;56(1):181-5. doi:10.1016/0002-9149(85)90590-9. PMID:3925749.